{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/meningitis-bacterial-meningitis-meningococcal-disease/management/without-non-blanching-rash/","result":{"pageContext":{"chapter":{"id":"414935f6-7030-5ea4-a397-cac8958da2c7","slug":"without-non-blanching-rash","fullItemName":"Scenario: Without non-blanching rash","depth":2,"htmlHeader":"<!-- begin field 46fdfc67-e859-4a9a-857f-ff60de3c175b --><h2>Scenario: Without non-blanching rash</h2><!-- end field 46fdfc67-e859-4a9a-857f-ff60de3c175b -->","summary":"Covers the pre-hospital management of suspected bacterial meningitis without non-blanching rash.","htmlStringContent":"<!-- begin item 15463ea5-0721-43be-be8c-a3ebe99dc5ff --><!-- begin field 1312ed80-f72e-439e-a97f-acd900ac5edc --><p>From birth onwards.</p><!-- end field 1312ed80-f72e-439e-a97f-acd900ac5edc --><!-- end item 15463ea5-0721-43be-be8c-a3ebe99dc5ff -->","topic":{"id":"5c52d7ca-c2cb-5551-ba9f-1fcdbdf1faad","topicId":"b3676823-9bef-422c-a1fe-011ca9f6883f","topicName":"Meningitis - bacterial meningitis and meningococcal disease","slug":"meningitis-bacterial-meningitis-meningococcal-disease","lastRevised":"Last revised in July 2020","chapters":[{"id":"12319bd7-3980-5b0c-8deb-b4351ef52f99","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"c72ab6e0-adbe-5cb4-9d67-4909820fb847","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"f9d67392-74e7-5adf-b712-fa42f7e69711","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"af144a12-5e1e-5d97-8d14-45db380ecef0","slug":"changes","fullItemName":"Changes"},{"id":"eb9e7802-cda3-5c04-b178-4ae4c2bb0003","slug":"update","fullItemName":"Update"}]},{"id":"9719c30a-3d48-51f7-8a76-d9a376cfc395","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"34af18fa-646e-5799-8eea-3070c9be3955","slug":"goals","fullItemName":"Goals"},{"id":"d1170912-4321-588d-88ca-217aea38c5c4","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"777fba00-f0b7-56ca-aad8-482a8107aa53","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"6162c8c1-72d4-5418-b083-e9261dc043af","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"8b16062f-23c7-57ef-9c04-d8696d43c468","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"141459fa-eb5f-51e0-a4f1-55aa8fcf568a","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"45808ab8-48c2-500e-904e-b28b1dd9f2c1","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"a71886c1-a30d-566c-84b9-d1fd02dbacd0","slug":"definition","fullItemName":"Definition"},{"id":"3bf2ba08-2574-58c3-9147-499dd2671f06","slug":"causes","fullItemName":"Causes"},{"id":"9d242c7b-d3c1-5081-8db2-1d366c43c71d","slug":"transmission","fullItemName":"Transmission"},{"id":"46f40806-a5d8-5742-ad5b-35abf21b89bb","slug":"prevalence","fullItemName":"Prevalence"},{"id":"20fadd0c-adea-5cb2-8cb7-cc9df62dd094","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"6f81c33d-8bac-5747-bd44-5b3244f57b58","slug":"complications","fullItemName":"Complications"},{"id":"6e9b6946-ed39-54a6-9e90-9989f22e636b","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"5bcb31df-47de-5f61-bdb9-90d4ff02c6c4","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"eeb07a78-3dda-516a-943d-8418d5224628","slug":"when-to-suspect","fullItemName":"When to suspect"},{"id":"5644216d-a652-51b5-a696-c9e4aac4b609","slug":"assessing-the-rash","fullItemName":"Assessing the rash"},{"id":"2fb8dc81-2176-50e5-a2c5-1bb1541cddfc","slug":"assessing-vital-signs","fullItemName":"Assessing vital signs"},{"id":"0f916e0f-ed47-5988-843a-19af47c3726d","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"75dbccb7-b3c5-51dc-8069-f497798fd646","fullItemName":"Management","slug":"management","subChapters":[{"id":"1b657d07-eb89-5d3b-9404-ef623a716920","slug":"non-blanching-rash-or-meningococcal-septicaemia","fullItemName":"Scenario: Non-blanching rash or meningococcal septicaemia"},{"id":"414935f6-7030-5ea4-a397-cac8958da2c7","slug":"without-non-blanching-rash","fullItemName":"Scenario: Without non-blanching rash"},{"id":"d532e29d-6fc3-54b3-b286-b1e80ce7840c","slug":"managing-close-contacts","fullItemName":"Scenario: Managing close contacts"},{"id":"81e1e9d4-a4c9-5c10-80d9-07cc83d6dba2","slug":"follow-up-after-hospital-discharge","fullItemName":"Scenario: Follow up after hospital discharge"}]},{"id":"c620569e-fa7a-5c2c-a708-ec6432bf5c51","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"9f59f8a5-e555-56ba-861a-a492cfe5a298","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"9c42a3ff-6a45-5e6c-a247-51a81848f67a","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"50077a62-1fb9-5968-a1e6-71ac64bcf7e1","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"7e85d7bc-8751-5e8f-8e77-8b91b0cf1141","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"7fb74eaa-420c-5cdd-a04e-92cbd9be478c","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"b8d54b7e-8c9b-5d53-8a0a-6a7296727eb4","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"71898679-d838-5f6d-8422-64c378e43045","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"75dbccb7-b3c5-51dc-8069-f497798fd646","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"e0af0721-82df-5ef3-be19-1fb81e5fc6df","slug":"management","fullItemName":"Management","depth":3,"htmlHeader":"<!-- begin field 3801fd1a-c8c6-4a25-9da4-bd594c3ed0c1 --><h3>How should I manage suspected bacterial meningitis without a non-blanching rash?</h3><!-- end field 3801fd1a-c8c6-4a25-9da4-bd594c3ed0c1 -->","summary":null,"htmlStringContent":"<!-- begin item 47e33983-c8c3-4e06-8b63-9b1043519692 --><!-- begin field 57b2ce11-229f-4ad3-99ef-757f5bfd7e28 --><ul><li><strong>Arrange emergency medical transfer to hospital by telephoning 999. </strong></li><li><strong>Do not give parenteral antibiotic treatment unless urgent transfer to hospital is not possible</strong> (for example in remote locations or owing to adverse weather conditions). <br><ul><li>Choice of empiric antibiotic will depend on availability or local policy. <ul><li>Options include benzylpenicillin, cefotaxime, or chloramphenicol. </li></ul></li></ul></li><li>If the person has no specific clinical features of bacterial meningitis, but it is not possible to exclude the person being in the early stages of the disease, admit to secondary care for a full assessment.</li></ul><!-- end field 57b2ce11-229f-4ad3-99ef-757f5bfd7e28 --><!-- end item 47e33983-c8c3-4e06-8b63-9b1043519692 -->","subChapters":[{"id":"d7f71d83-4fb0-5b40-99c2-1601315e1c11","slug":"basis-for-recommendation-e77","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 114e1c6e-065a-42dc-8049-e4bfc1602ed5 --><h4>Basis for recommendation</h4><!-- end field 114e1c6e-065a-42dc-8049-e4bfc1602ed5 -->","summary":null,"htmlStringContent":"<!-- begin item e7734f9c-e2b7-467b-b44d-f5ec5af31af5 --><!-- begin field 2a6f9d55-376a-4db4-9b94-30ad26d3ac49 --><p>These recommendations are based on the National Institute for Health and Care Excellence (NICE) guidelines <em>Bacterial meningitis and meningococcal septicaemia in children</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/meningitis-bacterial-meningitis-meningococcal-disease/references/\">NICE, 2018</a>] and <em>Sepsis: recognition, diagnosis and early management</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/meningitis-bacterial-meningitis-meningococcal-disease/references/\">NICE, 2017a</a>], the Meningitis Research Foundation (MRF) booklet <em>Meningococcal meningitis and sepsis. Guidance notes: diagnosis and treatment in general practice</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/meningitis-bacterial-meningitis-meningococcal-disease/references/\">Meningitis Research Foundation, 2018</a>], and the <em>British National Formulary</em> (BNF) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/meningitis-bacterial-meningitis-meningococcal-disease/references/\">Joint Formulary Committee, 2020</a>].</p><h5>Not routinely giving pre-hospital parenteral antibiotics in people with suspected meningitis without non-blanching rash</h5><ul><li>For children and young people with suspected meningitis without non-blanching rash, the NICE guideline development group (GDG) did not recommend giving pre-hospital parenteral antibiotics (unless urgent transfer to hospital is not possible) because [<a class=\"bibliography-reference internal-reference\" href=\"/topics/meningitis-bacterial-meningitis-meningococcal-disease/references/\">NICE, 2018</a>]:<ul><li>It found no high-quality evidence on the effects of pre-hospital antibiotics in children and young people with suspected bacterial meningitis.</li><li>It highlights that it is more usual to administer antibiotics in hospital than in primary care for these people. This is because:<ul><li>The rate of progression of the disease is slower when compared with septicaemia.</li><li>Lumbar puncture is usually performed <em>before</em> antibiotic administration. If lumbar puncture is not performed, it is difficult to distinguish bacterial meningitis from other illnesses that do not require antibiotic treatment.</li><li>Corticosteroids are used as adjunctive therapy for bacterial meningitis, and these should be administered before or with the first dose of antibiotics.</li><li>Antibiotic treatment should therefore be delayed until the diagnosis has been made by lumbar puncture in secondary care.</li></ul></li></ul></li></ul><h5>Antibiotic choice if urgent transfer to hospital is not possible</h5><ul><li style=\"list-style-type: none;\"><ul><li>These recommends are based on the BNF and the MRF guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/meningitis-bacterial-meningitis-meningococcal-disease/references/\">Meningitis Research Foundation, 2018</a>].</li><li>The BNF advises that [<a class=\"bibliography-reference internal-reference\" href=\"/topics/meningitis-bacterial-meningitis-meningococcal-disease/references/\">Joint Formulary Committee, 2020</a>]:<ul><li>If a patient with suspected bacterial meningitis without non-blanching rash cannot be transferred to hospital urgently, a single dose of benzylpenicillin should be given before the transfer. </li><li>In people with penicillin allergy, cefotaxime may be an alternative and chloramphenicol may be used if there is a history of immediate hypersensitivity reaction to penicillin or to cephalosporins.</li></ul></li></ul></li></ul><h5>Admitting to hospital if it is not possible to exclude early bacterial meningitis</h5><ul><li>This recommendation is pragmatic and is based on the serious medical consequences of misdiagnosing meningococcal disease, as highlighted by NICE [<a class=\"bibliography-reference internal-reference\" href=\"/topics/meningitis-bacterial-meningitis-meningococcal-disease/references/\">NICE, 2018</a>] and the Medical Defence Union [<a class=\"bibliography-reference internal-reference\" href=\"/topics/meningitis-bacterial-meningitis-meningococcal-disease/references/\">MDU, 2013</a>].</li></ul><!-- end field 2a6f9d55-376a-4db4-9b94-30ad26d3ac49 --><!-- end item e7734f9c-e2b7-467b-b44d-f5ec5af31af5 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}